Atlas Trials

Dabigatran Etexilate for Stroke Prevention in Patients With Atrial Fibrillation and Mild to Moderate Renal Impairment

Clinical trial NCT01721837 · COMPLETED

Trial details

NCT number
NCT01721837
Sponsor
Boehringer Ingelheim
Status
COMPLETED
Study type
OBSERVATIONAL
Atrial Fibrillation
Start date
2012-10-01
Primary completion
2013-06-01
Enrollment
4340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.